Dr. Chandrashekhar D Patil

Virus-host interactions @uiccom #Immunometabolism #METAbolomics #HSV-1 RT ≠ Endorsement

[Dr. Chandrashekhar D Patil @drcdpatil]

What a great start of 2022!
Thanks @J_Immunol for selecting our piece of work on the cover page #CoverArt #HSV #Optineurin #CCL5

[The Journal of Immunology @J_Immunol]

The January 1st issue of The Journal of Immunology is now available online: https://t.co/gpv8RQJxte
#Coverart provided by @DrShuklalab @thisisUIC

@J_Immunol is published by @ImmunologyAAI #societypublisher

[Dr. Chandrashekhar D Patil @drcdpatil]

This UIC and NEI-supported meeting brings together leading scientists and clinicians to discuss ocular immunity, infection, AI, and translational therapeutics.
Register today: https://t.co/PCQ7meABbg

[ARVO @ARVOinfo]

OMB proposed policies may drastically affect federal funding of research activities. @ARVOinfo believes in basing such decisions on expertise; peer review; scientific merit. We urge the #VisionResearch community to make your voice heard. Comment by July 13 https://t.co/uDcsrNAAmy

[ARVO @ARVOinfo]

Reserve your seat now for @ARVOinfo’s July 22 webinar to discover innovative strategies in experimental design aimed at minimizing animal use in #VisionResearch. Learn how to apply these approaches to your own projects. Sign up today: https://t.co/8RnhdmRCmI

[Dr. Chandrashekhar D Patil @drcdpatil]

@jonykipnis ♻️🤯😃

[ARVO @ARVOinfo]

OMB proposed policies may drastically affect federal funding of research activities. @ARVOinfo believes in basing such decisions on expertise; peer review; scientific merit. We urge the #VisionResearch community to make your voice heard. Comment by July 13 https://t.co/uDcsrNAAmy

[Dr. Chandrashekhar D Patil @drcdpatil]

Registration and abstract submissions are now open for the 2026 Symposium on Eye Inflammation and Infection (SEII) Chicago

[ARVO @ARVOinfo]

Excited for #ARVO2026 (May 3-7) in Denver? We have a whole week of social and networking events lined up for you to connect and collaborate with your peers. and/or enjoy downtime with your colleagues. Get more details here: https://t.co/YsXSAnoMl8
@ARVOinfo

[UICscience @UICscience]

@thisisUIC researchers have repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes.

This is especially helpful for immunocompromised patients, including cancer patients, who are vulnerable to HSV-1 infection.

▶️https://t.co/SVTnAMFTQF

[ARVO @ARVOinfo]

#ARVO2026 early-bird rates end today! Register and join us May 3 for the @ARVOinfo+@genentech Opening Keynote with Nobel Laureate Thomas Cech, PhD, and discover how #NucleicAcidTherapeutics could transform treatment for hereditary #GeneticEyeDiseases. https://t.co/kkQwEQFFgU

[ARVO @ARVOinfo]

Registered for #ARVO2026 yet? Join @ARVOinfo in vibrant Denver, Colo. (May 3-7) and immerse yourself in cutting-edge new eye/#VisionScience under the theme, Achieving precision ophthalmology through innovative #VisionResearch. Sign up by March 11 and save: https://t.co/hvP0OVo7lW

[Dr. Chandrashekhar D Patil @drcdpatil]

@MitoPsychoBio https://t.co/gTCFgXjBzS
Cosmic evolution could help unifying patterns.

[ARVO @ARVOinfo]

You can still secure a spot for @ARVOinfo's Jan. 13 webinar for insights and expert advice on navigating ethical challenges and the impacts of the environment on ophthalmic research, drug/device development, education, and patient care. Register today: https://t.co/8pOzoIa2H3

[ARVO @ARVOinfo]

Do not miss your opportunity to share your groundbreaking new #VisionResearch to a global audience at #ARVO2026 in Denver, Colo. (May 3 - 7)! Ensure your @ARVOinfo membership is active for 2026 and submit your abstract(s) by Dec. 5 (5pm ET). https://t.co/JN3ZMGrqtK
#ophthalmology

[ARVO @ARVOinfo]

Applications are open now for our #SciComm Training Fellowship—an incredible chance for early-career @ARVOinfo members to sharpen your #ScienceCommunication and #ScienceAdvocacy skills! Discover how this program can benefit you: https://t.co/87r0FOGSil
#SciCommTF

[Alliance for Vision Research @NAEVRAdvocacy]

Tomorrow kicks off our Emerging Vision Scientists Program and we are absolutely STOKED to welcome the largest cohort to date: 38 participants from nearly 30 institutions nationwide, plus a representative from the U.S. Army Institute of Surgical Research. #SeeWhatMatters

[Alliance for Vision Research @NAEVRAdvocacy]

Our Executive Director will be providing an update on the current landscape and funding updates related to the @NatEyeInstitute.

[Dr. Chandrashekhar D Patil @drcdpatil]

Happening soon...

[Prevent Blindness @PBA_savingsight]

Happening this Thursday!

The Senate is deciding funding for vision and eye health programs. That includes CDC’s Vision Health Initiative and NIH’s National Eye Institute. Cuts are on the table, which could impact care across the country.

Visit the @PBA_savingsight Legislative Action Center to ask your Senators to protect vision, eye health, and essential public health infrastructure.

https://t.co/Hb4hGcOQRe

@EyesOnCapHill

#preventblindness #advocacy

[Dr. Chandrashekhar D Patil @drcdpatil]

Link https://t.co/iGPSL53HlH

[Dr. Chandrashekhar D Patil @drcdpatil]

Calling all vision researchers! 🧠👁️
Present your work at UIC’s Eye Inflammation & Infection Symposium – Sept 12–14.
🏆 Abstracts due July 31 (eligible for awards!)
💡 Early bird registration is closing soon!
🔗 https://t.co/SPUVexqm0e
#Immunology #VisionScience #Ophthalmology